1[1]Miao ZH, Ding J. Transcription factor c-Jun activation represses mdr-1 gene expression[J]. Cancer Res, 2003, 63 (15):4527～4532.
2[2]Raaijmakers HG,Izquierdo MA,Lokhorst HM,et al.Lung resistance related protein expression is a negetive predictive factor for responseto conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma [J]. Blood,1998,91 (3):1029～1036.
3[3]Chretien A, Chataigner I, L'Helias N,et al. Complete and remarkable reversal of chemoselectivity in [4 + 2] cycloadditions involvingelectron-poor indoles as dienophiles. diels-alder versus hetero-diels-alderprocesses[J]. Org Chem, 2003, 68(21):7990～8002.
4[4]Dogruel M, Gibbs JE, Thomas SA, et al. Hydroxyurea transport across the blood-brain and blood-cerebrospinal fluid barriers of the guinea-pig[J]. Neurochemistry,2003,87(1):76～84.
5[5]Ueda K,Okamura N,Hirai M,et al.Human P-glycoprotein transports cortisol,aldosterone,and dexamethasone but not prog-esterone[J]. Biol Chem,1992,267(34):24248～24252.
6[6]Tanigawara Y,Okamura N,Hirai M, et al.Transport of di-goxin by human P-glycoprtein expressed in a porcine kidney epitheial cellline(LLC-PK1)[J]. Pharmacol Exp Ther, 1992, 263(2):840～845.
7[7]Saeki T, Ueda K, Tanigawara Y, et al. Human P-glycopro -tein transports cyclosporin A and FK506[J]. Biol Chem, 1993,268 (9):6077～6080.
8[8]Verstuyft C, Strabach S, El-Morabet H, et al. Dipyridame enhances digoxin bioavailability via P-glycoprotein inhibition[J]. ClinPharmacol Ther,2003,73(1):51～60.
9[9]Schinkel AH, Smit JJM, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barried and to increased sensitivity to drugs[J]. Cell, 1994,77:491～502.
10Cummins CL, Salphati L, Reid M J, et al. In vivo modulation of intestinal CYP3A metabolism by P- glycoprotein: studies using the rat single - pass intestinal perfusion model [ J ]. J Pharmacol Exp Ther, 2003;305: 306 - 314.
